Skip to main content
. 2017 Dec 6;14(2):322–328. doi: 10.1080/21645515.2017.1395538

Table 1.

Demographic characteristics at baseline.

  C. difficile toxoid vaccine (N = 68) Placebo (N = 34) All (N = 102)
Sexa      
 Male 38 (55.9%) 19 (55.9%) 57 (55.9%)
 Female 30 (44.1%) 15 (44.1%) 45 (44.1%)
Age (years)      
 Mean (SD) 53.8 (9.5) 57.3 (9.5) 54.9 (9.6)
 Median 50.2 57.8 51.5
 Min-Max 41.4–73.8 42.6–73.2 41.4–73.8
Age group (years)a      
 ≥40–64 53 (77.9%) 23 (67.6%) 76 (74.5%)
 ≥65–75 15 (22.1%) 11 (32.4%) 26 (25.5%)
a

Values represent the number (percentage) of participants